Charles River collaborates with Magellan Stem Cells
The companies are collaborating to advance stem cell and regenerative medicine development.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Charles River Collaborates With Magellan Stem Cells on Therapy Development
Charles River Laboratories and Australian biotech Magellan Stem Cells announced a collaboration to support development and clinical advancement of Magellan’s stem cell-based therapies and regenerative medicine.
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
For best results when printing this announcement, please click on link below: Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development Collaboration leverages next-generation sequencing (NGS) services to advance development and commercialization of an off-the-shelf